Allarity Therapeutics, Inc. Quarterly Depreciation in USD from Q3 2020 to Q1 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Allarity Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q3 2020 to Q1 2022.
  • Allarity Therapeutics, Inc. Depreciation for the quarter ending March 31, 2022 was $23K, a 58.9% decline year-over-year.
  • Allarity Therapeutics, Inc. annual Depreciation for 2021 was $12K, a 42.9% decline from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2022 $23K -$33K -58.9% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-27
Q3 2021 $22K -$16K -42.1% Jul 1, 2021 Sep 30, 2021 10-Q/A 2022-05-17
Q1 2021 $56K Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-27
Q3 2020 $38K Jul 1, 2020 Sep 30, 2020 10-Q/A 2022-05-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.